Fig. 4From: Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trialPost-palbociclib TTF by CTC number in patients treated with chemotherapy. CTCs categorized by < 5 and ≥ 5 CTCs cutoffBack to article page